- Can open-source R&D reinvigorate drug research?Bernard Munos
Bernard Munos is at Eli Lilly and Co, Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA
Nat Rev Drug Discov 5:723-9. 2006..Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?..
- A forensic analysis of drug targets from 2000 through 2012B Munos
InnoThink Center for Research in Biomedical Innovation, Indianapolis, Indiana, USA
Clin Pharmacol Ther 94:407-11. 2013..It examines their modes of action, highlights key trends, and discusses their implications for our ability to generate innovation...
- Can open-source drug R&D repower pharmaceutical innovation?B Munos
Corporate Strategy, Eli Lilly and Company, Indianapolis, Indiana, USA
Clin Pharmacol Ther 87:534-6. 2010..Is open innovation the answer to the innovation crisis? This Commentary argues that although it may likely be part of the solution, significant cultural, scientific, and regulatory barriers can prevent it from delivering on its promise...
- How to revive breakthrough innovation in the pharmaceutical industryBernard H Munos
InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228 1422, USA
Sci Transl Med 3:89cm16. 2011....